Research Hub · Skin & Aesthetic
Aging skin, thinning hair, scars, and the recovery window after a laser or microneedling session are four different aesthetic problems — and one peptide sits at the center of all of them, with three more filling the gaps. This hub covers what actually has evidence (more than most of this category), the logic for choosing by goal, and the GHK-Cu handling rules that make or break results.
Why This Hub Exists
Most peptide claims outrun the data. Skin is the exception. GHK-Cu — the copper tripeptide at the center of this hub — has decades of controlled research behind it: collagen synthesis, wound healing, hair growth comparable to minoxidil, and a genome-wide signature touching thousands of genes. That makes this category less about hype and more about using the right compound, the right way, for the right goal.
The Landscape
The Differentiator
What you're trying to improve routes to what gets used.
Mechanism, Plainly
GHK-Cu stimulates fibroblasts to produce collagen and elastin, and activates the copper-dependent enzyme that cross-links them. More collagen and better structure — not just more.
It clears damaged, disorganized collagen while laying down new organized collagen — remodeling rather than net degradation. This is what distinguishes it from simple collagen boosters and underlies its scar-prevention rationale.
By increasing dermal papilla size, GHK-Cu enlarges follicles and, in controlled trials, matched 2% minoxidil for hair density — with better tolerability. Assessment needs ~3 months to follow the hair cycle.
Anti-inflammatory and antioxidant activity plus a gene-expression signature that downregulates inflammation, fibrosis, and cellular senescence — the aging processes that degrade skin.
Evidence Snapshot
| Compound | Role | Status & evidence |
|---|---|---|
| GHK-Cu | Collagen / hair / repair | Cosmetic ingredient + research; controlled trials for wound healing, skin anti-aging, and hair. Strongest evidence in the peptide-aesthetics space. |
| CJC-1295 + Ipamorelin | GH-axis skin support | Research compounds; skin benefit is secondary to GH-axis effects. Fasted dosing rules apply. |
| Epithalon | Cellular aging | Research compound; longevity-oriented. Contraindicated with active cancer. |
| BPC-157 | Scar / wound | Research compound; preclinical wound-healing support. Cancer caution (angiogenic). |
Safety Screen
Common Questions
Not Sure Where You Fit?
About the Author
Full Disclaimer